Microsoft Word - 05-Takarabe.doc - Drug class - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2009-11-09 00:37:02 Medicinal chemistry Pharmacodynamics Pharmacokinetics Clinical pharmacology Biological databases Drug interaction Pharmaceutical drug KEGG Drug action DrugBank Drug class Mechanism of action		Microsoft Word - 05-Takarabe.doc Add to Reading List Source URL: www.jsbi.org Download Document from Source Website File Size: 820,17 KB Share Document on Facebook

	Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th DocID: 1uZFZ - View Document
	AprilMedications Requiring Prior Authorization for Medical Necessity for Clients with Advanced Control Specialty Formulary™ Below is a list of medicines by drug class that will not be covered without a prior aut DocID: 1uVOq - View Document
	Commonly Requested Special Authorization Drugs Therapeutic Category/ Drug Class DocID: 1uctK - View Document
	Letters RESEARCH LETTER Presence of Banned Drugs in Dietary Supplements Following FDA Recalls The US Food and Drug Administration (FDA) initiates class I DocID: 1sToy - View Document
	PRESS RELEASE Bicycle Therapeutics announces £20M ($32M) million financing for drug development Cambridge, UK, 14th OctoberBicycle Therapeutics, a next generation biotherapeutics company developing first-in-class DocID: 1rEWy - View Document